You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Relvar Ellipta 92/22mcg and 185/92mcg pack shot

Product overview

Relvar Ellipta is an ICS/LABA combination for the treatment of asthma and COPD [1] [2]. Relvar is the only ICS/LABA which is one inhalation, once daily which delivers 24 hours of continuous efficacy. For information about the differing licensed doses in asthma and COPD, please see Indications page.

*SMC= Scottish Medicines Consortium

ǂ AWMSG= All Wales Medicines Strategy Group

Innoviva logo

Relvar, Incruse and Ellipta are registered trademarks of the GlaxoSmithKline group of companies